Welcome!
Trendlines Group
Funds
Trendlines appointed agrifood tech co-investor by Enterprise Singapore's Seeds Capital
SINGAPORE (Jan 16): Trendlines Group says its new US$40 million Singapore venture fund ($54.2 million) has been appointed as a partner under the Startup SG Equity scheme, which is administered by Enterprise Singapore investment arm Seeds Capital.
January 16, 2019
Broker's Calls
Trendlines remains undervalued and 'overweight': NRA
SINGAPORE (June 28): NRA Capital is reiterating its “overweight” recommendation on Trendlines Group with a fair value estimate of 22.5 cents.
June 28, 2018
Trendlines receives FDA regulatory clearance for meniscus repair system
SINGAPORE (June 19): Trendlines Group announced that its portfolio company, Arcuro Medical, has received regulatory clearance from the United States Food and Drug Administration (FDA) for its SuperBall meniscus repair system.
June 19, 2018
Trendlines' Saturas completes investment round of US$4 mil
SINGAPORE (Feb 26): Trendlines announced that its portfolio company Saturas has completed an investment round of US$4 million ($5.27 million).
February 26, 2018
Trendlines teams up with Ozi Amanat as Startup SG Equity co-investors
SINGAPORE (Feb 8): Trendlines Medical Singapore, a subsidiary of Israeli company The Trendlines Group, is partnering Singapore-based investor Ozi Amanat’s venture capital firm, K2 Global, to collaborate in SPRING SEEDS Capital’s (SSC) $100 million inv
February 08, 2018
In print this week
Finally, some good news for long-suffering Trendlines investors
SINGAPORE (Dec 8): The Trendlines Group’s announcement at end-October that it will start paying dividends in the next financial year could boost returns for long-suffering shareholders of the medical technology incubator.
December 08, 2017
Trendlines Medical makes maiden investment in medical device startup
SINGAPORE (Oct 16): Trendlines Medical Singapore, a 76.43%-owned subsidiary of Catalist-listed Israeli company The Trendlines Group, has made its first investment by committing a total of US$60,000 ($81,150) to a medical device start-up, InterVaal.
October 16, 2017
Trendlines in private placement to raise $14 mil
SINGAPORE (Oct 10): Trendlines Group, the investor, incubator and developer of early-stage medical and agricultural startup in Israel is raising net proceeds of $13.34 million by placing out 100 million new shares at 14.03 cents each.
October 10, 2017
Trendlines to sell entire 6% stake in MitrAssist Medical for US$1.15 mil
SINGAPORE (Aug 30): A subsidiary of Trendlines Group is disposing its entire 6% stake in MitrAssist Medical for a consideration of US$1.15 million ($1.55 million).
August 30, 2017
Trendlines joint fund establishes new company to research crop protection
SINGAPORE (June 27): Trendlines Group, the Catalist-listed innovation commercialisation company based in Israel, has announced that its Bayer Trendlines Ag Innovation Fund will be establishing a new company, ABI-Ag, to conduct specific research in the fie
June 27, 2017